The Food and Drug Administration has granted Fast Track designation to ATH434 for the treatment of multiple system atrophy.

“We have now succeeded in generating cyclic peptides that bind to a disease target of our choice and can also be administered orally,” said research lead Christian Heinis, PhD. “To this ...

BGE-102 is a structurally novel, orally available small-molecule NLRP3 inhibitor with high potency and brain penetration. BioAge is initially developing BGE-102 for the treatment of obesity.

One reason that it’s so difficult to deliver large protein drugs orally is that these drugs can’t pass through the mucus barrier that lines the digestive tract. This means that insulin and ...

Their research opens the door to a new class of orally available drugs, addressing a long-standing challenge in the pharmaceutical industry. There are many diseases for which the targets were ...

New research has demonstrated the safety and tolerability of a new drug treatment designed as a therapeutic intervention for spinal cord injury (SCI). New research from the Institute of Psychiatry ...

Researchers from Anew Therapeutics Pte Ltd. recently detailed the discovery of novel oral IL-17A small-molecule inhibitors as candidates for the treatment of psoriasis.

Dermatologists who specialize in hair loss say that the key ingredient in a topical treatment worked even better when taken orally at a low dose. By Gina Kolata The ads are everywhere — and so ...